Menveo is a conjugate vaccine manufactured by GlaxoSmithKline (GSK) designed to protect against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W135, and Y. The vaccine combines polysaccharides conjugated to a carrier protein, which enhances immunogenicity and provides long-lasting protection. Each dose includes one vial of lyophilized MenA conjugate to be reconstituted with the MenCWY liquid conjugate component. It is administered intramuscularly and is suitable for use in adolescents and adults as per immunization guidelines. Menveo helps in the prevention of life-threatening meningitis and septicemia, particularly for high-risk groups, international travelers, and during outbreaks.
Specifications
- Service at Doorstep : FREE Home vaccination availability
- Cold Chain Compliance : Maintains 2-8°C
- VACCINATION KIT : AVAILABLE
- VACCINATION OFFICER : YES